Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates
January 04, 2024 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides an update on the clinical development of its oral first-in-class...
ORION BIOTECHNOLOGY WELCOMES NEW MEMBERS OF SCIENTIFIC ADVISORY BOARD
April 13, 2021 10:05 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, April 13, 2021 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company focused on precision engineering small protein therapeutics, today...
CU Anschutz Medical Campus Enterprise Launches Revolutionary Drug Test That Takes the Guesswork Out of Drug Use and Misuse
January 07, 2014 09:06 ET
|
CU Toxicology
DENVER, CO--(Marketwired - Jan 7, 2014) - For the first time, treatment providers will be able to see a complete picture of their patients' drug use and misuse using a revolutionary new drug test...
Tranzyme Pharma Secures Additional $9.3 Million Debt Financing
February 01, 2012 16:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it received an additional net $9.3 million in term loan proceeds through an amendment...